Killing people for organ harvesting
Why are the media doing this? This is why.
Adrenaline, Organ Harvesting, and the Death of our daughter Paloma Scarlet Shemirani: A Forensic and Ethical Indictment
We have all of the evidence.
Copyright © Kate Shemirani 2025. All rights reserved.
The PARAMEDIC-2 trial concluded that adrenaline improves short-term survival, but not neurological outcomes, and its cost-effectiveness is only justifiable when the value of organ donation is included. This raises critical ethical questions regarding the real motives behind continued adrenaline use, especially when administered to patients who may not even be in cardiac arrest.
In the case of our daughter Paloma Scarlet Shemirani, a 23-year-old multilingual Cambridge graduate, the evidence shows that she was never in cardiac arrest, yet she was given adrenaline doses equivalent to 12 times what her body weight would warrant, and administered via intraosseous She was also given paralysing agents, via femoral line in our home commonly used to facilitate organ procurement, not recovery. The truth is undeniable: she did not die of cancer. She died from gross negligence manslaughter.
The PARAMEDIC-2 Trial: Survival or Supply Chain?
The original trial (Perkins et al., N Engl J Med, 2018) showed adrenaline improved return of spontaneous circulation (ROSC), but most survivors suffered severe brain damage. A 2020 economic analysis published in Resuscitation revealed the following:
“Adrenaline was not cost-effective when only directly related costs and consequences are considered. However, incorporating the indirect economic effects associated with transplanted organs substantially alters cost-effectiveness.”
pubmed.ncbi.nlm.nih.gov/32981529/#
This admits that organ donation was factored in as a justification for giving adrenaline, despite its failure to improve real patient-centred outcomes.
Paloma’s Case: No Cardiac Arrest, No Consent, Yet Overdosed.
Prepped for Procurement?
Body weight: 37 kg (5 stone 12 lbs approx. Petite )
Adrenaline given: Far in excess x 12 and too rapidly of BNF dosage (which is 10mcg/kg in cardiac arrest)
LifePak logs show pulse and oxygen saturation present
Witnessed bystander and mother confirm she was monitored breathing and a heartbeat
Use of intraosseous (IO) and then femoral line indicates aggressive access and typically used donation scenarios
Use of paralysing agents (e.g., Rocuronium), Identical to those used during controlled organ donation.
We believe she was treated as if she were a donor, not a patient.
Removal of Paraphernalia and Concealment of Evidence
At post-mortem, no medical lines or cannulae were retained
No toxicology was performed despite repeated family requests
Coroner did not notify the family before autopsy, breaching Regulations
Coroner now claims cause of death is not important
No brain imaging was performed before withdrawal of life support
EEG confirmed brain activity, but ventilation was removed anyway
Was Paloma Used in PARAMEDIC-3,Live Protocol Trial?
PARAMEDIC-3 trial was currently live in East Sussex, adrenaline protocols with intra osseous gun
Informed consent not required under s251 exemptions in emergencies
Conducted in collaboration with Warwick University and Professor Gavin Perkins, who has also worked with GlaxoSmithKline, manufacturer of adrenaline/EpiPens
Matt Hancock (former Health Secretary) stated in 2021:
“Britain will become a global leader in organ donation… supplying organs to the Commonwealth.”
nhsbtdbe.blob.core.windows.net/umbraco-assets…
This aligns with a strategic shift towards harvesting organs from brain-dead donors using policies masked as public health improvement.
Creating donors?
Warning
Paloma was not in cardiac arrest, she was lucid, eating, interacting hours before. She fainted, then deteriorated only after the arrival of the ambulance team and their drug protocols. Unprotected. She was treated as state property, and the actions taken mirror what is seen in live organ procurement, not life-saving medicine